Patents by Inventor Beatriz Banfi Tosi

Beatriz Banfi Tosi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of vaginal insulin sensitizing agents
    Patent number: 9339458
    Abstract: A method for the treatment and/or prevention of hyperandrogenism and/or polycystic ovary syndrome and/or related disorders comprising the vaginal administration of at least one insulin-sensitizing agent.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: May 17, 2016
    Assignee: ITF RESEARCH PHARMA, S.L.U.
    Inventors: Jaime Moscoso Del Prado, Beatriz Banfi Tosi
  • USE OF VAGINAL INSULIN SENSITIZING AGENTS
    Publication number: 20150164788
    Abstract: A method for the treatment and/or prevention of hyperandrogenism and/or polycystic ovary syndrome and/or related disorders comprising the vaginal administration of at least one insulin-sensitising agent.
    Type: Application
    Filed: November 7, 2014
    Publication date: June 18, 2015
    Inventors: Jaime MOSCOSO DEL PRADO, Beatriz BANFI TOSI
  • Pharmaceutical compositions containing sulphonic acid derivatives
    Publication number: 20060160849
    Abstract: A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR8 formula group, where R8 is H, OH, NR10R11, independently from one another, where R10 and R11 represent H or C1-C6 alkyl or a group of formula NH—CO—R12, where R12 is C1-C6 alkyl or C6-C10 aryl; R1 and R2 represent H or SO3R9, independently from one another, where R9 is H, ammonium or a cation of an alkali or alkaline-earth metal; R3 is H or OH; and R4, R5, R6 and R7 represent H, an NR10R11 or NH—CO—R12 group, independently from one another; on the condition that (i) at least one of R1 or R2 is SO3R9, and (ii) at least one of R4, R5, R6 or R7 is an NR10R11 or NH—CO—R12 group, or their pharmaceutically acceptable salts; and a pharmaceutically acceptable excipient.
    Type: Application
    Filed: March 5, 2004
    Publication date: July 20, 2006
    Inventors: Beatriz Banfi Tosi, Guillermo Gimenez Gallego, Serafin Valverde Lopez, Rosa Lozano Puerto, Pedro Sanchez Cuevas